283 filings
Page 2 of 15
6-K
8g46r 0j2ti2c
24 May 23
Kamada Announces $60 Million Private Placement with FIMI Opportunity Funds
7:00am
6-K
wghw7mw
17 May 23
Report of Foreign Private Issuer
7:00am
6-K
g2ygfx3qb
16 May 23
Kamada Announces Receipt of Marketing Authorization for Glassia® for Treatment of Alpha-1 Antitrypsin Deficiency in Switzerland
7:00am
6-K
4y1soew
3 May 23
Kamada Announces U.S. FDA Approval of its Application to Manufacture CYTOGAM® at the Company’s Facility in Israel
7:00am
6-K
d4py9adp36wamfyum pl
15 Mar 23
Kamada Issues 2023 CEO Letter to Shareholders
7:18am
6-K
zrc6ltv 9p
15 Mar 23
Report of Foreign Private Issuer
7:16am
6-K
74khhrn0n3wrzaprcx3w
15 Mar 23
Kamada Reports Strong Fiscal Year and Fourth Quarter 2022 Financial Results, and Provides 2023 Guidance Representing Significant Profitability Growth
7:10am
6-K
wg46cg v15v
9 Mar 23
Report of Foreign Private Issuer
8:17am
6-K
mx7jb57hg dd731zp
4 Jan 23
Kamada Announces Submission of Application to the U.S. FDA to Manufacture CYTOGAM® at the Company’s Facility in Israel
7:00am
6-K
zsw i9y6dqd
22 Dec 22
Report of Foreign Private Issuer
9:00am
6-K
3mk9 p0tr53xk4
19 Dec 22
Kamada Announces Planned Transition of Chief Financial Officer
7:03am
6-K
gsyw7mfv
22 Nov 22
Kamada Reports Strong Third Quarter Financial Results Demonstrating Successful Strategic Transition and Reiterates 2022 Financial Guidance
7:00am
6-K/A
il4jrjd
17 Nov 22
Current report (foreign) (amended)
1:08pm
6-K
jt86z
16 Nov 22
Report of Foreign Private Issuer
7:00am
6-K
zhfrmrqhk60hm 520b
8 Nov 22
Notice of Annual General Meeting of Shareholders
7:02am
6-K
ixuhn8 o245
7 Nov 22
Kamada Provides Update on Recent Progress Achieved in Ongoing Pivotal Phase 3 Clinical Trial of Inhaled AAT
7:00am
6-K
4e4t3a 86
26 Oct 22
Kamada to Present at the Credit Suisse 31st Annual Healthcare Conference
7:00am
6-K
fr4pita6x9kk4uefj
19 Oct 22
Kamada Awarded $22 Million Extension of Canadian Supply Tender
7:00am
6-K
isdwmtvqths1yj
17 Aug 22
Report of Foreign Private Issuer
7:00am
6-K
gf4h fh3b4
10 Aug 22
Report of Foreign Private Issuer
12:00am